Healthcare stocks were edging higher pre-bell Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.6% and the iShares Biotechnology ETF (IBB) advancing by 1.3%.
Nuvation Bio (NUVB) stock was up more than 3% after the company said the FDA has approved its supplemental New Drug Application for IBTROZI (taletrectinib), a ROS1 inhibitor for locally advanced or metastatic ROS1-positive non-small cell lung cancer.
Indivior Pharmaceuticals (INDV) shares were up more than 3% after the company said its board has declared a special cash dividend of $8.13 per share to holders of record as of Oct. 30.
IDEXX Laboratories (IDXX) has expanded its Faecal Dx antigen testing platform in the UK to detect taeniid tapeworms, including Taenia and Echinococcus species, the company said. IDEXX Laboratories stock was up more than 1% premarket.